Facing challenges, Deciphera cuts workforce by a third
01 Dec 2021 //
BIOPHARMADIVE
Deciphera Presents Data from Rebastinib, its TIE2 Inhibitor Program
17 Sep 2020 //
PIPELINEREVIEW
Deciphera Presents Data from Rebastinib, its TIE2 Inhibitor Program
16 Sep 2020 //
BUSINESSWIRE
Deciphera Pharma Presents Preliminary Data from Ph1b/2 Study of Rebastinib
29 May 2020 //
BUSINESSWIRE